Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui Qin

Showing results (851-860 of 861) with videos related to

Pageof 87
Sort By:
Cell Death & Disease|May 19, 2021
Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTENYong-Qu Zhang, Yuan-Ke Liang, Yang Wu, et al.
Ebiomedicine|August 30, 2016
SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast CancerLauren L Siewertsz van Reesema, Vasilena Zheleva, Janet S Winston, et al.
Blood Advances|September 18, 2023
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphomaLoretta J Nastoupil, Georg Hess, Miguel A Pavlovsky, et al.
Chinese Medical Journal|April 27, 2011
Preliminary molecular epidemiology of the Staphylococcus aureus in lower respiratory tract infections: a multicenter study in ChinaDe-Zhi Li, Yu-Sheng Chen, Jing-Ping Yang, et al.
Environmental Science & Technology|July 17, 2024
Prenatal Parental Exposure to Metals and Birth Defects: A Prospective Birth Cohort StudyHong Lv, Yangqian Jiang, Kan Ye, et al.
Chinese Medical Journal|November 2, 2010
Drug-resistant genes carried by Acinetobacter baumanii isolated from patients with lower respiratory tract infectionNing Dai, De-zhi Li, Ji-chao Chen, et al.
The New England Journal of Medicine|June 3, 2022
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell LymphomaMichael L Wang, Wojciech Jurczak, Mats Jerkeman, et al.
Cell Research|March 16, 2024
Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humansLin Fan, Junwei Liu, Wei Hu, et al.
The Lancet Regional Health. Western Pacific|November 6, 2023
Real-world tobacco cessation practice in China: findings from the prospective, nationwide multicenter China National Tobacco Cessation Cohort Study (CNTCCS)Zhao Liu, Rui Qin, Xue-Jun Hu, et al.
Cell|May 14, 2026
A comparison of deep multiomics profiles across ethnicity, geography, and ageNasim Barapour, John Z Cao, Yue Wu, et al.
Pageof 87

Showing results (851-860 of 861) with videos related to

Sort By:
Pageof 87
Cell Death & Disease|May 19, 2021
Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTENYong-Qu Zhang, Yuan-Ke Liang, Yang Wu, et al.
Ebiomedicine|August 30, 2016
SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast CancerLauren L Siewertsz van Reesema, Vasilena Zheleva, Janet S Winston, et al.
Blood Advances|September 18, 2023
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphomaLoretta J Nastoupil, Georg Hess, Miguel A Pavlovsky, et al.
Chinese Medical Journal|April 27, 2011
Preliminary molecular epidemiology of the Staphylococcus aureus in lower respiratory tract infections: a multicenter study in ChinaDe-Zhi Li, Yu-Sheng Chen, Jing-Ping Yang, et al.
Environmental Science & Technology|July 17, 2024
Prenatal Parental Exposure to Metals and Birth Defects: A Prospective Birth Cohort StudyHong Lv, Yangqian Jiang, Kan Ye, et al.
Chinese Medical Journal|November 2, 2010
Drug-resistant genes carried by Acinetobacter baumanii isolated from patients with lower respiratory tract infectionNing Dai, De-zhi Li, Ji-chao Chen, et al.
The New England Journal of Medicine|June 3, 2022
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell LymphomaMichael L Wang, Wojciech Jurczak, Mats Jerkeman, et al.
Cell Research|March 16, 2024
Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humansLin Fan, Junwei Liu, Wei Hu, et al.
The Lancet Regional Health. Western Pacific|November 6, 2023
Real-world tobacco cessation practice in China: findings from the prospective, nationwide multicenter China National Tobacco Cessation Cohort Study (CNTCCS)Zhao Liu, Rui Qin, Xue-Jun Hu, et al.
Cell|May 14, 2026
A comparison of deep multiomics profiles across ethnicity, geography, and ageNasim Barapour, John Z Cao, Yue Wu, et al.
Pageof 87